The reality is that the key to building an important and valuable company usually lies somewhere in between meddling and focus.

Early stage advanced materials companies are most often born with a healthy dose of science in their DNA. However, as these companies evolve from the lab to the commercial world, the art of business must be genetically engineered in. In our experience working with early stage advanced materials companies, focus is one of the most delicate genes to effectively insert. Focus is a true art: on the one hand, there is a temptation to meddle in every possible application. On…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?